Immunosuppressive therapy with rituximab in common variable immunodeficiency

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Mol Allergy
Egile Nagusiak: Pecoraro, Antonio, Crescenzi, Ludovica, Galdiero, Maria Rosaria, Marone, Giancarlo, Rivellese, Felice, Rossi, Francesca Wanda, de Paulis, Amato, Genovese, Arturo, Spadaro, Giuseppe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://ncbi.nlm.nih.gov/pubmed/31080365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak